Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Argenx's Ambitious Plans For Efgartigimod On Track
Second Compound, ARGX-117, Shows Potential
Aug 25 2021
•
By
Kevin Grogan
argenx has set out its strategy up to 2025 • Source: Alamy
Keep up with the top pharma business news of the week. On the go.
Scrip brings you a weekly bulletin of top picks.
More from Strategy
More from Business